← Eichor
Condition: Prognostic Cancer Model Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prognostic Cancer Model

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized C
Phase N/A · 1 location(s) · Mingzhao Xiao · NCT06088134Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035Colorectal Cancer Dataset in Xijing Hospital From 2011
Phase N/A · 1 location(s) · Xijing Hospital · NCT06308354COLO-COHORT (Colorectal Cancer Cohort) Study
Phase N/A · 3 location(s) · South Tyneside and Sunderland NHS Foundation Trust · NCT04185779Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype
Phase N/A · 1 location(s) · Military University Hospital, Prague · NCT05929365Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Phase N/A · 1 location(s) · Oslo University Hospital · NCT02073500ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Phase N/A · 13 location(s) · Stanford University · NCT02848274Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model
Phase N/A · 2 location(s) · Fudan University · NCT06202404Validation of RCC Predicting Model With Emulated-target Trial
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07117227Tissue Collection for Studies of Lymph Cancer
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT01676805Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
Phase N/A · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06364371Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT04212910AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
Phase N/A · 4 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06286267Prognostic Significance of ctDNA in HL
Phase N/A · 5 location(s) · Interni hematologicka klinika FNKV · NCT06263530Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
Phase 3 · 1 location(s) · Elisabethinen Hospital · NCT06391892Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT07608003Radiation-Related Dysphagia Development Prediction Using a Two-Step Ultrasonographic Model (R-2D-2)
Phase N/A · 1 location(s) · Hopital Forcilles · NCT06387004Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
Phase N/A · 1 location(s) · Young-Joon Kang · NCT07327970Sarcopenia and Systemic Therapy in HCC
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06805552A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07305727
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.